Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
Abstract
A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.
- Inventors:
- Issue Date:
- Research Org.:
- Univ. of Missouri, Columbia, MO (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1531467
- Patent Number(s):
- 6680045
- Application Number:
- 09/841,407
- Assignee:
- The Curators of the University of Missouri (Columbia, MO)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- DOE Contract Number:
- FG02-93ER61661
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 2001-04-24
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 62 RADIOLOGY AND NUCLEAR MEDICINE
Citation Formats
Jurisson, Silvia S., Quinn, Thomas P., and Giblin, Michael F. Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma. United States: N. p., 2004.
Web.
Jurisson, Silvia S., Quinn, Thomas P., & Giblin, Michael F. Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma. United States.
Jurisson, Silvia S., Quinn, Thomas P., and Giblin, Michael F. Tue .
"Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma". United States. https://www.osti.gov/servlets/purl/1531467.
@article{osti_1531467,
title = {Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma},
author = {Jurisson, Silvia S. and Quinn, Thomas P. and Giblin, Michael F.},
abstractNote = {A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2004},
month = {1}
}
Works referenced in this record:
Cyclic Melanotropins. 9. 7-D-Phenylalanine Analogues of the Active-Site Sequence
journal, May 1985
- Cody, Wayne L.; Mahoney, Mark; Knittel, James J.
- Journal of Medicinal Chemistry, Vol. 28, Issue 5
Synthesis and Characterization of Rhenium-Complexed α-Melanotropin Analogs
journal, May 1997
- Giblin, Michael F.; Jurisson, Silvia S.; Quinn, Thomas P.
- Bioconjugate Chemistry, Vol. 8, Issue 3
Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
patent, January 2002
- Jurisson, Silvia S.; Quinn, Thomas P.; Giblin, Michael F.
- US Patent Document 6,338,834
Radiolabeled peptides and other ligands for receptors overexpressed in tumor cells for imaging neoplasms
journal, August 1996
- McAfee, John G.; Neumann, Ronald D.
- Nuclear Medicine and Biology, Vol. 23, Issue 6
Works referencing / citing this record:
Metal abstraction peptide (MAP) tag and associated methods
patent, March 2015
- Stowell Laurence, Jennifer Ann; Vartia, Anthony Andrew; Krause, Mary Elizabeth
- US Patent Document 8,975,082
Metal abstraction peptide (MAP) tag and associated methods
patent, October 2012
- Laurence, Jennifer Ann Stowell; Vartia, Anthony Andrew; Krause, Mary Elizabeth
- US Patent Document 8,278,111
Metal abstraction peptide (MAP) tag and associated methods
patent, August 2015
- Stowell Laurence, Jennifer Ann; Vartia, Anthony Andrew; Krause, Mary Elizabeth
- US Patent Document 9,096,652
Metal abstraction peptide with superoxide dismutase activity
patent, November 2015
- Stowell Laurence, Jennifer Ann; Krause, Mary Elizabeth; Jackson, Timothy A.
- US Patent Document 9,187,735